quinazolines has been researched along with Autism in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Greengard, P; Hu, Z; Lin, L; Liu, T; Ma, K; Matas, E; Seo, JS; Wang, J; Wang, ZJ; Yan, Z; Yang, F; Zhang, F; Zhong, P | 1 |
Bassell, GJ; Gross, C; Horn, PS; Poopal, AC; Schroeder, LM | 1 |
2 other study(ies) available for quinazolines and Autism
Article | Year |
---|---|
Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice.
Topics: Animals; Autistic Disorder; Disease Models, Animal; Female; Haploinsufficiency; Histone-Lysine N-Methyltransferase; Histones; Male; Methylation; Mice; Microfilament Proteins; Nerve Tissue Proteins; Prefrontal Cortex; Quinazolines | 2020 |
Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Topics: Adenine; Autistic Disorder; Biomarkers; Cell Line; Class I Phosphatidylinositol 3-Kinases; Diseases in Twins; Enzyme-Linked Immunosorbent Assay; Family Health; Female; Humans; Lymphocytes; Male; Molecular Targeted Therapy; Nerve Tissue Proteins; Phosphorylation; Protein Processing, Post-Translational; Quinazolines; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |